Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-006616
Filing Date
2020-05-14
Accepted
2020-05-14 16:50:41
Documents
55
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aptx-20200331x10q.htm 10-Q 1061913
2 EX-31.1 aptx-20200331ex311c678bd.htm EX-31.1 25510
3 EX-31.2 aptx-20200331ex312e59baa.htm EX-31.2 25542
4 EX-32.1 aptx-20200331ex3217e83b3.htm EX-32.1 16531
5 GRAPHIC aptx20200331x10q001.jpg GRAPHIC 35634
  Complete submission text file 0001558370-20-006616.txt   4243812

Data Files

Seq Description Document Type Size
6 EX-101.INS aptx-20200331.xml EX-101.INS 922831
7 EX-101.SCH aptx-20200331.xsd EX-101.SCH 27325
8 EX-101.CAL aptx-20200331_cal.xml EX-101.CAL 31261
9 EX-101.DEF aptx-20200331_def.xml EX-101.DEF 93240
10 EX-101.LAB aptx-20200331_lab.xml EX-101.LAB 243486
11 EX-101.PRE aptx-20200331_pre.xml EX-101.PRE 204456
Mailing Address 909 DAVIS STREET SUITE 600 EVANSTON IL 60201
Business Address 1801 MAPLE AVENUE SUITE 4300 EVANSTON IL 60201 847-871-0377
Aptinyx Inc. (Filer) CIK: 0001674365 (see all company filings)

EIN.: 474626057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38535 | Film No.: 20878564
SIC: 2834 Pharmaceutical Preparations